OsimertinibDrug resistance secondary to C797S mutation and pneumonitis : 2 case reports

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2019年 / 1740卷 / 1期
关键词：
D O I：
10.1007/s40278-019-58148-3
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：255 / 255
相关论文
共 50 条
  • [21] Concomitant ALK translocation and EGFR C797S mutation as resistance mechanisms to osimertinib in an EGFR-mutant NSCLC patient
    Pons-Tostivint, Elvire
    Hulo, Pauline
    Sagan, Christine
    Papazyan, Thomas
    Herbreteau, Guillaume
    Denis, Marc
    RESPIRATORY MEDICINE AND RESEARCH, 2024, 86
  • [22] Icotinib in a lung adenocarcinoma patient with acquired EGFR 19del/C797S mutation-mediated resistance to osimertinib: a case report
    Cai, Fei
    Zhao, Yuanyuan
    Song, Shuxi
    Zhao, Dong
    Zheng, Zhendong
    Xu, Long
    ANTI-CANCER DRUGS, 2024, 35 (08) : 764 - 768
  • [23] Discovery of a small-molecule inhibitor that can target EGFR with C797S mutation
    Kim, Dongsu
    Son, Woo Seung
    Jang, Anna
    Lee, Yeri
    Kim, Donggeon
    Choi, Changyu
    Min, Kyung Hoon
    Choi, Sung Pil
    Lim, Sang Kyun
    CANCER RESEARCH, 2022, 82 (12)
  • [24] Afatinib/gefitinib/osimertinibDrug resistance: 3 case reports
    Reactions Weekly, 2019, 1773 (1) : 18 - 18
  • [25] Synthesis, activity, and their relationships of 2,4-diaminonicotinamide derivatives as EGFR inhibitors targeting C797S mutation
    Kageji, Hideaki
    Momose, Takayuki
    Nagamoto, Yasuhito
    Togashi, Noriko
    Yasumatsu, Isao
    Nishikawa, Yosuke
    Kihara, Kawori
    Hiramoto, Kumiko
    Minami, Megumi
    Kasanuki, Naomi
    Isoyama, Takeshi
    Naito, Hiroyuki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2024, 98
  • [26] Overcoming C797S mutation: The challenges and prospects of the fourth-generation EGFR-TKIs
    Zhao, Hong-Yi
    Xi, Xiao-Xiao
    Xin, Minhang
    Zhang, San-Qi
    BIOORGANIC CHEMISTRY, 2022, 128
  • [27] Effect of EGFR C797S/G mutation on osimertinib resistance in Chinese patients with non-small-cell lung cancer
    Nie, Keke
    Zhang, Zhongfa
    Zhang, Chunling
    Lan, Ketao
    Ji, Youxin
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [28] The EGFR C797S Mutation Confers Resistance to a Novel EGFR Inhibitor CLN-081 to EGFR Exon 20 Insertion Mutations
    Kagawa, Yosuke
    Hayashida, Takuma
    Liu, Jie
    Mori, Shunta
    Izumi, Hiroki
    Kumagai, Shogo
    Udagawa, Hibiki
    Hattori, Noboru
    Goto, Koichi
    Kobayashi, Susumu S.
    JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (03):
  • [29] Osimertinib and chemotherapy combination to treat brain metastasis flare and osimertinib resistance by EGFR C797S
    Bautista Blaquier, Juan
    Recondo, Gonzalo
    JOURNAL OF CHEMOTHERAPY, 2023, 35 (02) : 168 - 172
  • [30] Acquired EGFR Resistance Mutation C797S in Pancreatic Adenocarcinoma Following Partial Response to Third-Generation EGFR Inhibitor Therapy
    Papa, Brigitte
    Dorwal, Pranav
    Htain, Pamela
    Robin, Julie
    Tan, C. P.
    Singhal, Nimit
    JCO PRECISION ONCOLOGY, 2024, 8
12345